Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gliknik Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10933
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gliknik Inc (Gliknik) is a biopharmaceutical company that develops therapies for patients suffering from cancer and immune disorders. The company’s pipeline products include biropepimut-S (GL-0817) and GL-2045. Its biropepimut-S is an engineered peptide immunomodulator targeted against important epitopes within the cancer protein MAGE-A3. Gliknik designs recombinant GL-2045 to mimic the structure and efficacy of the very small and variable portion of the pooled human blood product IVIG, which is an active fraction in treating autoimmune disorders. The company partners with pharmaceutical industries. Gliknik is headquartered in Baltimore, Maryland, the US.

Gliknik Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9
Gliknik Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gliknik Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Gliknik Raises Funds through Venture Financing 11
Gliknik Raises US$2.8 Million In Venture Financing 12
Gliknik Raises US$10 Million In Series B Financing 13
Licensing Agreements 14
Gliknik Enters Into Licensing Agreement With Pfizer For GL-2045 14
Gliknik Inc – Key Competitors 15
Gliknik Inc – Key Employees 16
Gliknik Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Gliknik Inc, Pharmaceuticals & Healthcare, Key Facts 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9
Gliknik Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gliknik Raises Funds through Venture Financing 11
Gliknik Raises US$2.8 Million In Venture Financing 12
Gliknik Raises US$10 Million In Series B Financing 13
Gliknik Enters Into Licensing Agreement With Pfizer For GL-2045 14
Gliknik Inc, Key Competitors 15
Gliknik Inc, Key Employees 16

List of Figures
Gliknik Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hoosier Energy Rural Electric Cooperative, Inc.:発電所・企業SWOT分析
    Hoosier Energy Rural Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, …
  • Patria Oyj:企業の戦略・SWOT・財務分析
    SummaryPatria Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • Globaltrans Investment PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Globaltrans Investment PLC Merg …
  • AND International Publishers NV (AND):企業の財務及び戦略的SWOT分析
    Summary AND International Publishers NV (AND) is a software developer company that provides digital mapping data used for navigation and location-based services. The company offers AND navigation maps, digital maps and geocoding maps. It provides road database, a vector based digital road map used f …
  • Philips Healthcare-医療機器分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Kunlun Energy Co., Ltd. (135):企業の財務及び戦略的SWOT分析
    Summary Kunlun Energy Co., Ltd. (Kunlun), a subsidiary of PetroChina Company Limited is an investment holding company that explores and produces crude oil and natural gas. The company’s exploration and production projects include K & K project, Indonesia Bengara-II project, Kazakhstan Aktobe project …
  • Sterling Construction Company, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sterling Construction Company, …
  • Taiwan Cooperative Bank, Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mauna Kea Technologies SAS (MKEA):製薬・医療:M&Aディール及び事業提携情報
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Taylor Corporation:企業の戦略・SWOT・財務情報
    Taylor Corporation - Strategy, SWOT and Corporate Finance Report Summary Taylor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Smith Micro Software, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Smith Micro Software, Inc. Merg …
  • JEA:企業の発電所・SWOT分析2018
    JEA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • Dominium S.A.:企業の戦略・SWOT・財務情報
    Dominium S.A. - Strategy, SWOT and Corporate Finance Report Summary Dominium S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Atlas Iron Ltd:企業のM&A・事業提携・投資動向
    Atlas Iron Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atlas Iron Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Iron Mountain Incorporated:企業のM&A・提携・投資分析
    Iron Mountain Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iron Mountain Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Cellectricon AB(製薬・医療分野):企業M&A動向
    Summary Cellectricon AB (Cellectricon) is a biotechnology company. The company provides automated cell-based screening technologies for drug discovery and basic research in the pharmaceutical and biotechnology industries. Its technologies concentrate on ion-channel screening and cell engineering. Ce …
  • ZPEB International:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "ZPEB International" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follow …
  • CIMB Group Holdings Berhad (CIMB):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "CIMB Group Holdings Berhad" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …
  • Oclaro, Inc. (formerly Bookham, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Oclaro, Inc. (formerly Bookham, …
  • MetGen Oy:企業のM&A・提携動向(エネルギー分野)
    Summary MetGen Oy (MetGen) is a biotechnology company that develops, produces and markets enzymatic solutions for industrial customers. The company offers proprietary MetZyme which is an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applicati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆